Shift from visceral to subcutaneous adipose tissue in Cyp17a1-knockout rats prevents the progression of metabolic syndrome
PLOS One · 12.12.2025 · 20 (12) · e0311478
DOI: 10.1371/journal.pone.0311478 ↗Kurz gefasst
Kommentar in der Zeitschrift PLOS One, online erschienen am 12.12.2025. Verfasst von Beom-Jin Jeon und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Theriogenology and Biotechnology, Department of Veterinary Clinical Science, College of Veterinary Medicine, BK21 FOUR Future Veterinar…. Hauptthemen laut MEDLINE: Metabolic Syndrome, Subcutaneous Fat, Intra-Abdominal Fat, Steroid 17-alpha-Hydroxylase. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: BK21 Four for Future Veterinary Medicine Leading Education and Research Center, National Research Foundation of Korea, Ministry of Food and Drug Safety.
Abstract (Originalsprache)
In this study, we investigated the effects of Cyp17a1 gene knockout (KO) on obesity and metabolic syndrome. Cyp17a1 KO in rats using CRISPR-Cas9 resulted in sex dimorphism and obesity, and interestingly, site-specific accumulation was found in subcutaneous adipose tissue (SAT). Surprisingly, an insulin tolerance test and oral glucose tolerance test did not show any issues with insulin sensitivity and secretion despite hyperglycemia. In addition, Cyp17a1 KO rats showed normal plasma insulin and free fatty acid levels compared to wild-type rats, and blood biochemistry analysis revealed normal triglyceride, total cholesterol, high-density lipoprotein, and low-density lipoprotein levels. Cyp17a1 KO adipose-tissue-derived stem cells from SAT showed increased expression of KLF5, an early adipogenesis marker, which implies enhanced adipogenic potential in SAT. When gene expression associated with lipid, glucose, and insulin metabolism as well as inflammation in adipose tissue was examined, a metabolic shift to SAT was discovered in the Cyp17a1 KO group. In conclusion, in the Cyp17a1 KO rat models we generated for the first time, the phenotype promoted by obesity reflected metabolically healthy obesity hypothesis, but this did not exhibit metabolic syndrome-like features due to enhanced metabolism in the SAT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Laboratory of Theriogenology and Biotechnology, Department of Veterinary Clinical Science, College of Veterinary Medicine, BK21 FOUR Future Veterinary Medicine Leading Education, and the Research Institute of Veterinary…
- Comparative medicine Disease Research Center, Seoul National University, Seoul, Republic of Korea.
- K-BIO KIURI Center, Seoul National University, Seoul, Republic of Korea.
- Department of Veterinary Nutrition, College of Veterinary Medicine, Seoul National University, Republic of Korea.
- LARTBio Incorp., Gyeonggi-Do, Republic of Korea.
ORCID-Profile: Jeong-Hwa Lee, Goo Jang
Förderung
- BK21 Four for Future Veterinary Medicine Leading Education and Research Center
- National Research Foundation of Korea
- Ministry of Food and Drug Safety
Zitieren
APA
Jeon, B. J., Lee, J. H., Kwon, D. H., Kim, H. K., & Jang, G. (2025). Shift from visceral to subcutaneous adipose tissue in Cyp17a1-knockout rats prevents the progression of metabolic syndrome. PLOS One, 20(12), e0311478. https://doi.org/10.1371/journal.pone.0311478
Vancouver
Jeon BJ, Lee JH, Kwon DH, Kim HK, Jang G. Shift from visceral to subcutaneous adipose tissue in Cyp17a1-knockout rats prevents the progression of metabolic syndrome. PLOS One. 2025;20(12):e0311478. doi:10.1371/journal.pone.0311478
BibTeX
@article{Jeon2025,
author = {Jeon, Beom-Jin and Lee, Jeong-Hwa and Kwon, Dong-Hyeok and Kim, Hee-Kyoung and Jang, Goo},
title = {Shift from visceral to subcutaneous adipose tissue in Cyp17a1-knockout rats prevents the progression of metabolic syndrome},
journal = {PLOS One},
year = {2025},
volume = {20},
number = {12},
pages = {e0311478},
doi = {10.1371/journal.pone.0311478}
}
EUVIMED